We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$90.5B
1-Year Est. Return
33.95%
This Fund
S&P 500
This Quarter
Est. Return
+23.44%
1 Year Est. Return
+33.95%
3 Year Est. Return
+77.62%
5 Year Est. Return
+56.06%
10 Year Est. Return
+196.47%
AUM
$90.5B
AUM Growth
+$5.41B
(+6.4%)
Cap. Flow
-$1.73B
Cap. Flow
% of AUM
-1.91%
Top 10 Holdings %
Top 10 Hldgs %
20.12%
Holding
5,141
New
939
Increased
1,573
Reduced
1,769
Closed
818
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$732M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$553M |
| 3 |
Applied Materials
AMAT
|
+$327M |
| 4 |
Intuit
INTU
|
+$320M |
| 5 |
Chevron
CVX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$651M |
| 3 |
Microsoft
MSFT
|
+$344M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$298M |
| 5 |
Qualcomm
QCOM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.2% |
| 2 | Technology | 14.41% |
| 3 | Healthcare | 5.76% |
| 4 | Consumer Discretionary | 5.56% |
| 5 | Financials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COAG
3951
Hemab Therapeutics
COAG
$2.07B
| $230K | ﹤0.01% |
+6,252
| New | +$173K |
|
|
MRLN
3952
Merlin Inc
MRLN
$339M
| $230K | ﹤0.01% |
+40,336
| New | +$341K |
|
3953
CALL
Steel Dynamics
STLD
$34.7B
| $229K | ﹤0.01% |
+1,000
| New | +$234K |
|
3954
CALL
Ameriprise Financial
AMP
$49.5B
| $229K | ﹤0.01% |
+500
| New | +$229K |
|
|
JCAP
3955
Jefferson Capital
JCAP
$1.23B
| $229K | ﹤0.01% |
+11,767
| New | +$219K |
|
3956
CALL
CRISPR Therapeutics
CRSP
$5.39B
| $229K | ﹤0.01% |
4,200
-5,700
| -58% | -$300K |
|
3957
Oaktree Specialty Lending
OCSL
$1.15B
| $229K | ﹤0.01% |
19,182
-59,018
| -75% | -$712K |
|
3958
CALL
Enovix
ENVX
$729M
| $228K | ﹤0.01% |
37,600
-20,300
| -35% | -$135K |
|
3959
Standard BioTools
LAB
$269M
| $228K | ﹤0.01% |
+277,375
| New | +$262K |
|
3960
ProKidney
PROK
$420M
| $228K | ﹤0.01% |
111,763
-99,344
| -47% | -$182K |
|
3961
Brown-Forman Class B
BF.B
$12.3B
| $227K | ﹤0.01% |
+8,528
| New | +$230K |
|
3962
HighPeak Energy
HPK
$1.02B
| $227K | ﹤0.01% |
+32,467
| New | +$224K |
|
3963
Timberland Bancorp
TSBK
$361M
| $227K | ﹤0.01% |
+5,058
| New | +$209K |
|
3964
Cytokinetics
CYTK
$10.1B
| $226K | ﹤0.01% |
+2,655
| New | +$191K |
|
3965
PUT
iShares MSCI Turkey ETF
TUR
$220M
| $226K | ﹤0.01% |
5,800
-14,900
| -72% | -$606K |
|
3966
Union Bankshares
UNB
$118M
| $225K | ﹤0.01% |
+9,261
| New | +$223K |
|
3967
RCI Hospitality Holdings
RICK
$224M
| $224K | ﹤0.01% |
+8,216
| New | +$208K |
|
3968
Taylor Devices
TAYD
$201M
| $224K | ﹤0.01% |
3,821
-2,126
| -36% | -$115K |
|
3969
Verra Mobility
VRRM
$619M
| $224K | ﹤0.01% |
52,680
+39,449
| +298% | +$416K |
|
3970
CALL
Krystal Biotech
KRYS
$10.6B
| $223K | ﹤0.01% |
+600
| New | +$179K |
|
3971
SB Financial Group
SBFG
$187M
| $223K | ﹤0.01% |
+8,812
| New | +$195K |
|
3972
HealthStream
HSTM
$854M
| $222K | ﹤0.01% |
+8,149
| New | +$191K |
|
3973
CALL
Ventas
VTR
$46.3B
| $222K | ﹤0.01% |
2,500
-1,000
| -29% | -$85.2K |
|
3974
CALL
Consolidated Edison
ED
$39.7B
| $221K | ﹤0.01% |
2,000
-35,500
| -95% | -$3.86M |
|
3975
CALL
Asbury Automotive
ABG
$3.9B
| $221K | ﹤0.01% |
+1,100
| New | +$217K |
|
Similar funds
VM
Squarepoint's Q2 2026 Portfolio in Review
As of Q2 2026, Squarepoint held 5,141 positions worth $90.5B, up 6.4% from $85.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Squarepoint's Q2 2026 filing shows 939 new, 1,573 increased, 1,769 reduced and 818 closed positions. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 4,852,366 shares worth $520M. The largest sale was iShares Core S&P 500 ETF, an estimated $3.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
- Squarepoint's largest Q2 2026 buy was State Street Communication Services Select Sector SPDR ETF: 4,852,366 shares worth $520M.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $732M increase.
- Squarepoint's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $3.03B.
- Squarepoint fully exited VanEck Semiconductor ETF in Q2 2026, selling an estimated $192M.
- Squarepoint's ten largest holdings make up 20% of its $90.5B portfolio in Q2 2026.
- Squarepoint opened 939 new positions and closed 818 in Q2 2026.
- Squarepoint's portfolio value rose 6.4% quarter-over-quarter to $90.5B.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.